Anthelmintic treatment of pastured dairy cattle in California

The relationship of anthelmintic treatment for subclinical gastrointestinal nematode parasitism with resultant milk production was studied on 3 California dairies where animals were maintained on a pasture-based nutritional program. All of the animals that started lactating (freshened) during a 12-month period participated in trials in which coumaphos was given as a feed top dressing to animals averaging 30 days into lactation. All of the animals that freshened during the subsequent 12-month period from 2 of the same 3 dairies participated in trials in which thiabendazole was administered at or within 2 weeks before freshening. Anthelmintic administration during 2 consecutive lactation cycles under the conditions of the present study resulted in no consistent reproducible significant changes in milk production.     

Pharmacokinetics of eprinomectin in plasma and milk following topical administration to lactating dairy cattle

The pharmacokinetics and mammary excretion of eprinomectin were determined in cattle following topical administration at a dose rate of 0.5 mg kg(-1). The kinetics of plasma and milk concentrations were analysed using a one-compartment model. The maximum plasma concentration of 43.76 ng ml(-1)occurred 2.02 days post administration, and the mean residence time was 4.16 days. Eprinomection was detected in the milk at the first sampling time and thereafter for at least 15 days. Comparison of the milk and plasma data demonstrated the parallel disposition of the drug in the milk and plasma with a milk / plasma concentration ratio of 0. 102+/-0.048. The amount of drug recovered in the milk during this period was 0.109% +/- 0.038 of the total administered dose. This very low extent of mammary excretion resulted in low concentrations of eprinomectin in milk. This supports the permitted use in lactating cattle, as the maximum level of residue in milk did not exceed the maximum acceptable limit of 30 ng ml(-1).     

Predicting milk-production responses after an autumn treatment of pastured dairy herds with eprinomectin

The objectives of this study were (1) to determine the effect of a treatment with eprinomectin in autumn of pastured dairy herds on the anti-Ostertagia ostertagi bulk-tank milk antibody level, (2) to determine the overall effect of this treatment on three milk-production parameters (milk yield, protein % and fat %) and (3) to investigate the value of the pre-treatment Ostertagia-specific bulk-tank milk antibody level to predict the production response after anthelmintic treatment. One hundred and nineteen herds in Flanders (Belgium) were randomly assigned to a treatment with eprinomectin or a placebo in October 2004. Bulk-tank milk samples were collected monthly from August 2004 until April 2005, and the antibody levels against O. ostertagi were determined as optical density ratios (ODRs) with an ELISA. The treatment effect over the 4 months following treatment on three production parameters (milk yield, milk-protein %, milk-fat %) was estimated by mixed models with herd as a random effect. The treatment effect on milk yield was also investigated within six categories of the pre-treatment ODR. The ODR values were lower in the eprinomectin group than in the control group at each time point after treatment. The overall effect on milk yield was estimated at 1.2 kg/cow/day, whereas no effect on the milk-protein % and milk-fat % was observed. Herds in the highest pre-treatment ODR category (>0.84) had a positive milk-yield response of 4.0 kg/cow/day (95%-confidence interval: 1.0; 7.0), while the 95%-confidence intervals of the milk-yield responses in the other categories all included zero. This study demonstrates that treatment with eprinomectin of pastured dairy cows in autumn will lower the Ostertagia-specific bulk-tank milk antibody level during the stabling period and can result in a consistent increase in milk yield. The results indicate that an O. ostertagi bulk-tank milk ELISA can be used to identify the herds where the greatest milk-yield response after an anthelmintic treatment is expected.     

Nematode burdens of pastured cattle treated once at turnout with eprinomectin extended-release injection

The efficacy of eprinomectin in an extended-release injection (ERI) formulation was evaluated against infections with third-stage larvae or eggs of gastrointestinal and pulmonary nematodes in cattle under 120-day natural challenge conditions in a series of five studies conducted in the USA (three studies) and in Europe (two studies). For each study, 30 nematode-free (four studies) or 30 cattle harboring naturally acquired nematode infections (one study) were included. The cattle were of various breeds or crosses, weighed 107.5–273 kg prior to treatment and aged approximately 4–11 months. For each study, animals were blocked based on pre-treatment bodyweight and then randomly allocated to treatment: ERI vehicle (control) at 1 mL/50 kg bodyweight or Eprinomectin 5% (w/v) ERI at 1 mL/50 kg bodyweight (1.0 mg eprinomectin/kg) for a total of 15 and 15 animals in each group. Treatments were administered once on Day 0 by subcutaneous injection in front of the shoulder. In each study, all animals grazed one naturally contaminated pasture for 120 days. At regular intervals during the studies, fecal samples from all cattle were examined for nematode egg and larval counts. In four studies pairs of tracer cattle were used to monitor pasture infectivity at 28-day intervals before and/or during the grazing period. All calves were weighed before turnout onto pasture and at regular intervals until housing on Day 120. For parasite recovery, all study animals were humanely euthanized 27–30 days after removal from pasture.     

The effect of eprinomectin treatment at calving on reproduction parameters in adult dairy cows in Canada

A clinical trial was carried out in two provinces of Canada to investigate the effect of treatment with eprinomectin at calving on production parameters in adult dairy cattle in 1999-2000. One of the objectives of this study was to evaluate the impact of treatment on reproductive performance as measured by: calving-to-conception interval, calving-to-first service interval and number of services per conception. The ability of an indirect ELISA using a crude adult Ostertagia ostertagi antigen to predict response to treatment also was evaluated. All lactating cows in 20 dairy herds were allocated randomly to receive either eprinomectin pour-on or placebo at calving. Information on reproductive parameters was obtained from computerised cow records. Survival models were used to evaluate the effect of treatment on the two intervals and a Poisson model was used to evaluate the number of services to conception. A total of 549 cows were included in these analyses. A marginally significant treatment effect on calving-to-conception interval was observed (hazard ratio=1.24, P=0.06) but not on calving-to-first service interval. A significant reduction in the number of breedings to conception for treated animals also was observed with a longer effect in cows with short interval to first service. Milk samples from a subset of 109 late-lactation cows were tested for antibodies against O. ostertagi. The ELISA optical-density ratio (ODR) values obtained between 120 days before calving and drying off were categorised as high ODR (>or=0.5) and low ODR (<0.5). Among untreated animals, the hazard of conception was lower (hazard ratio=0.38, 95% CI=[0.19,0.75]) for high-ODR cows compared to low ODR cows suggesting that higher parasite burdens had an adverse effect on reproductive performance. Treated high-ODR cows had a hazard of conception equivalent to the hazard for all cows in the low-ODR group (indicating that treatment prevented the negative effect associated with these higher parasite burdens).     

Effect of eprinomectin treatment on milk yield and quality in dairy cows in South Tyrol, Italy

The effect of treatment with eprinomectin on milk yield, milk composition and somatic cell counts (SCCs) was studied in 105 dairy cows located on seven farms in South Tyrol, Italy. On each farm, half of the animals were treated with eprinomectin and the other half were used as an untreated control group. Three test day records per animal were obtained before treatment (days -117, -75 and -33) and another three test day records were obtained after treatment (days 22, 62 and 131). Test day records comprised milk yield, milk composition, SCC and days in milk. On the day of treatment, blood samples and faecal samples were taken for parasitological analysis. Cows with positive faecal egg counts yielded less milk. A significant effect of eprinomectin on milk yield was observed after treatment and was most pronounced on the second and the third test days after treatment (+1.90 kg [P=0.002] and +2.63 kg [P<0.001], respectively). Furthermore, a significant decrease in SCC was observed on the second test day after treatment.     

The effect of repeated, four-weekly eprinomectin treatment on milk production in pasture-based, seasonally-calving dairy cattle

A randomised clinical trial from the North Island of New Zealand was conducted to assess the effect of repeated anthelmintic treatment on milk production, and to assess factors that affect treatment response. Nine hundred and twenty three multiparous, lactating dairy cattle from three pasture-based, spring-calving dairy herds were enrolled in this trial. Within each herd, cattle were stratified on age and calving date, and were randomly allocated to treatment (n=319) or control (n=604) groups. The treatment group received ≥0.05mg/kg of topical eprinomectin every 28 days for eight treatments during lactation. Pooled-milk from treated cows and bulk-milk samples were obtained at each treatment and analysed with an Ostertagia antibody ELISA, expressed as optical density ratios (ODR). Bi-monthly milk data were collected and expressed as energy-corrected milk (kg/day; ECM). A linear mixed model was used to analyse ECM, with cow as the random effect. The effect of anthelmintic treatment on days from calving, and start-of-mating, to conception were analysed with Cox-proportional hazard models. ODR values ranged from 0.6 to 1.3; there were no differences in ODR between herds (p=0.12), or between pooled-milk from treated cows and bulk-milk (p=0.26). Repeated treatments had no effect on daily ECM yields (p=0.74). However, there was a significant treatment×herd interaction (p=0.03); treatment increased ECM in one herd by 0.781kg/cow/day (p=0.015), but resulted in a non-significant decrease in the other two herds. A curvilinear interaction existed between days-in-milk and treatment response (p=0.039); the greatest treatment effect occurred during mid-lactation. Previous year milk production (p=0.46) and age (p=0.11) did not influence the effect of treatment on ECM. Treatment had no effect on any reproductive parameter. In conclusion, under New Zealand pastoral conditions, anthelmintic treatment increased milk production in one herd, but had no effect in two other herds. Further work is needed to identify why this variation in gastro-intestinal parasitism occurs.     

Crossbreeding effects on milk yield traits and calving interval in spring‐calving dairy cows

The aim of the study was to assess crossbreeding effects for 305‐day milk, fat, and protein yield and calving interval (CI) in Irish dairy cows (parities 1 to 5) calving in the spring from 2002 to 2006. Data included 188 927 records for production traits and 157 117 records for CI. The proportion of genes from North American Holstein Friesian (HO), Friesian (FR), Jersey (JE) and Montbéliarde (MO) breeds, and coefficients of expected heterosis for HO×FR, HO×JE and HO×MO crosses were calculated from the breed composition of cows’ parents. The model used to assess crossbreeding effects accounted for contemporary group, age at calving within parity, linear regression on gene proportions for FR, JE and MO, and linear regression on coefficients of expected heterosis for HO×FR, HO×JE and HO×MO, as fixed effects, and additive genetic, permanent environmental and residual as random. Breed effects for production traits were in favour of HO, while for CI were in favour of breeds other than HO. The highest heterosis estimates for production were for HO×JE, with first‐generation crosses yielding 477 kg more milk, 25.3 kg more fat, and 17.4 kg more protein than the average of the parental breeds. The highest estimate for CI was for HO×MO, with first‐generation crosses showing 10.2 days less CI than the average of the parental breeds. Results from this study indicate breed differences and specific heterosis effects for milk yield traits and fertility exist in Irish dairy population.     

提高乳牛奶产量和奶品质的几项措施

自三鹿奶粉事件以后,人们对牛奶的品质要求更高,养牛户对乳牛的产奶量更加关注,那么我们怎样做才能更好的提高乳牛奶产量和奶品质呢?科学的饲养管理是提高乳牛的奶产量和奶品质的主要途径,喂给丰富的、易消化的饲料,可提高奶中脂肪和蛋白质的含量.     

Effect of calving age on genetic evaluation of milk yield in Holstein cattle

Tropical Animal Health and Production - The aim of this study was to evaluate the effect of including calving age (CA) on genetic evaluation models for Holstein cattle. The evaluated models...     

不同粗饲料对奶牛乳产量和乳成分的影响

选择18头荷斯坦奶牛,设置3个处理,每个处理6个重复,每个重复1头奶牛,研究不同粗饲料对奶牛泌乳性能和乳成分的影响,3个处理的粗饲料分别为玉米秸(Ⅰ组)、玉米秸+青贮玉米秸(Ⅱ组)、羊草(Ⅲ组)。试验结果表明:①试验Ⅱ组与试验Ⅲ组平均产奶量差异不显著(P>0.05),试验全期分别比Ⅰ组提高了8.82%(P<0.05)和9.57%(P<0.05);②不同处理间的乳糖、乳脂含量差异不显著(P>0.05);对于乳蛋白,在试验40d时3个试验组差异不显著(P>0.05),在第15d时Ⅱ组、Ⅲ组分别比Ⅰ组降低了7.43%(P<0.05)和8.57%(P<0.05)。对于乳干物质,Ⅱ组与Ⅲ组差异不显著(P>0.05)。根据上述生产性能指标综合评定,玉米秸+青贮玉米秸可有效替代羊草饲喂奶牛,而不降低泌乳性能。     

Effect of a peri-parturient eprinomectin treatment of dairy cows on milk production

AIM: To quantify and economically evaluate the effect on milk production of peri-parturient treatment of dairy cows with eprinomectin. METHODS: On 3 farms in separate geographic areas of New Zealand, 849 first-calf heifers and multiparous cows were ranked and paired within parity, date of calving and expected milk production. Within pairs, cows were randomly allocated to treatment with either a commercial formulation of eprinomectin, applied at a dose rate of 500 mug/kg liveweight, or an equivalent volume of vehicle containing no antiparasitic agent and administered at the same dose volume, generally within the first week post-calving. On each farm, trial cows shared the same pasture. Over a single lactation, records were maintained of milk quantity and content. RESULTS: Trichostrongylid eggs were identified in pre-treatment faecal samples from all farms, verifying the presence of gastrointestinal parasites. Overall 25.5% of the cows sampled were positive for nematode eggs, but only 8% had counts 50 eggs per gram of faeces (epg). Daily milk volume, milk protein and milksolids (yield of milk fat + milk protein) were higher for eprinomectin-treated multiparous cows than for controls (milk volume: 20.36 l/day vs 19.76 l/day, p=0.005; milk protein: 0.700 kg/day vs 0.685 kg/day, p=0.012; milksolids: 1.613 kg/day vs 1.583 kg/day, p=0.031, respectively). The daily value of the increased production from eprinomectin-treated multiparous cows was estimated to be NZ0.034 dollar for milk fat (p=0.095) and NZ0.078 dollar for milk protein (p=0.012), equating to NZ0.104 dollars for milksolids (p=0.031), averaged over the whole lactation. No significant difference in milk production was detected between treated and control first-calf heifers. Averaged over the whole herd, the peri-parturient treatment of multiparous cows and first-calf heifers with eprinomectin increased daily milk volume and milk protein production of treated vs control cows (19.28 l/day vs 18.86 l/day, p=0.020, and 0.661 kg/day vs 0.650 kg/day, p=0.047, respectively). CONCLUSION: These data provide evidence that the use of a peri-parturient treatment of eprinomectin on multiparous cows can increase their production of fluid milk and milksolids.     

Effect of eprinomectin pour-on treatment around calving on reproduction parameters in adult dairy cows with limited outdoor exposure

The objective of this study was to investigate if treatment of cows with eprinomectin around calving had any beneficial effects on the calving to first artificial insemination interval, calving to conception interval, and number of services per conception in totally- and semi-confined dairy herds. In totally-confined herds lactating- and dry-cows were housed throughout the summer and had no access to pasture. In semi-confined herds lactating- and dry-cows had limited outdoor exposure to a small pasture or paddock but were still fed a ration that met all their nutritional requirements. The study was carried out between February 2002 and February 2003 in 35 herds (2381 cows) located in Quebec, Ontario and Minnesota (USA) participating in a larger clinical trial. The herds kept electronic reproduction records. Cows were randomly allocated to receive eprinomectin or a placebo, with treatment being administered on or close to the day of calving. Monthly bulk tank milk samples from each farm were tested with an indirect ELISA using a crude Ostertagia ostertagi antigen and these data were averaged over the study year. The optical density ratio (ODR) values were then dichotomized into high and low using a cut-point of 0.50. Treatment effects were analyzed using Cox proportional hazards survival models with herd frailty effects for calving to conception and calving to first service intervals. Aalen's linear hazards model was used to investigate time-varying effects in the Cox models. A random effects poisson regression model was used to model the number of services per conception. Other predictor variables tested in the models were lactation number, calving season, study site, peak milk production, ODR and the lactating- and dry-cow housing variables. Overall, there was no significant effect of treatment on the three indices of reproductive performance. The effect of season of calving depended on how much time had passed since calving. Presumably this effect reflected a seasonal effect at the time of breeding. Hazard of conception in younger cows was higher than in older cows. Early bred cows tended to have a higher number of inseminations per conception than those bred late. The results of the study suggested that eprinomectin treatment at calving was not beneficial to reproduction.     

Plasma disposition and faecal excretion of eprinomectin following topical and subcutaneous administration in non-lactating dairy cattle

AIMS: To investigate the plasma disposition and faecal excretion of eprinomectin (EPM) in non-lactating dairy cattle following topical and S/C administration.

METHODS: Holstein dairy cows, 3.5–5 years-old, were selected 20–25 days after being dried off and were randomly allocated to receive EPM either topically (n=5) or S/C (n=5) at dose rates of 0.5 and 0.2?mg/kg bodyweight, respectively. Heparinised blood and faecal samples were collected at various times between 1 hour and 30 days after treatment, and were analysed for concentrations of EPM using high performance liquid chromatography with a fluorescence detector.

RESULTS: The maximum concentration of EPM in plasma (C_max) and the time to reach C_max were both greater after S/C administration (59.70 (SD 12.90) ng/mL and 1.30 (SD 0.27) days, respectively) than after topical administration (20.73 (SD 4.04) ng/mL and 4.40 (SD 0.89) days, respectively) (p<0.001). In addition, S/C administration resulted in greater plasma availability (area under the curve; AUC), and a shorter terminal half-life and mean residence time (295.9 (SD 61.47) ng.day/mL; 2.95 (SD 0.74) days and 4.69 (SD 1.01) days, respectively) compared with topical administration (168.2 (SD15.67) ng.day/mL; 4.63 (SD 0.32) days, and 8.23 (SD 0.57) days, respectively) (p<0.01). EPM was detected in faeces between 0.80 (SD 0.45) and 13.6 (SD 4.16) days following S/C administration, and between 1 (SD 0.5) and 20.0 (SD 3.54) days following topical administration. Subcutaneous administration resulted in greater faecal excretion than topical administration, expressed as AUC adjusted for dose (1188.9 (SD 491.64) vs. 311.5 (SD 46.90) ng.day/g; p<0.05). Maximum concentration in faeces was also higher following S/C than topical administration (223.0 (SD 63.96) vs. 99.47 (SD 43.24) ng/g; p<0.01).

CONCLUSIONS: Subcutaneous administration of EPM generated higher plasma concentrations and greater plasma availability compared with topical administration in non-lactating cattle. Although the S/C route provides higher faecal concentrations, the longer faecal persistence of EPM following topical administration may result in more persistent efficacy preventing establishment of incoming nematode larvae in cattle.     

Effect of a treatment with eprinomectin or trichlorfon on the yield and quality of milk produced by multiparous dairy cows

The effects of a strategic antiparasitic treatment against Hypoderma species and other parasites on the milk yield, composition, and somatic cell counts of 742 multiparous dairy cattle were investigated on 79 farms in a Hypoderma species-endemic area in western Switzerland; 357 of the cows were treated with eprinomectin, 252 with trichlorfon, and 133 were left untreated. The treatments were given between October and early December 1998, on average 53 days before calving. Milk yield, fat, protein and somatic cell counts were measured once a month until the end of lactation. Eprinomectin and trichlorfon significantly increased milk yield during the first month after treatment compared with the control cows by 2.14 (P < 0.001) and 2.50 kg per day (P < 0.001), respectively. Initially, the difference between the eprinomectin- and trichlorfon-treated animals was not significant, but the effect of eprinomectin on milk yield was persistent, whereas the effect of trichlorfon decreased significantly by 0.12 kg per day per month (P < 0.05). The somatic cell counts increased significantly slower in the treated cows than in the control cows (P < 0.05). Milk composition was not affected by the treatments.     

饲料甜菜对奶牛产奶量的影响

目的：为探索在奶牛日粮中添加饲料甜菜对其泌乳量的影响,提高奶牛养殖的经济效益。方法：2011年9月20日至11月20日,选择健康黑白花奶牛6头,随机分为试验组（饲料甜菜组）和对照组（普通饲料组）,进行饲料甜菜对奶牛产奶量的影响试验。结果：试验组比对照组头均日产奶量增加2 kg,产奶量提高7.9%,差异极显著（P〈0.01）;试验组比对照组粗饲料采食量增加14%,饲料成本增加504元,差异极显著（P〈0.01）;试验组比对照组头日均收入高6.8元,增加纯收入1 124元,经济效益提高13.2%,差异极显著（P〈0.01）。结论：饲料甜菜饲喂奶牛,牛奶产量和质量明显提高,经济效益提高,在实践中应大力推广。     

Bovine respiratory syncytial virus reinfections and decreased milk yield in dairy cattle

Summary

The influence of Bovine Respiratory Syncytial Virus (BRSV) reinfections on the daily milk yield was studied by evaluating the milk production of 32 BRSV reinfected cows. For the estimation of milk production losses, four lactation curve models were used, including a gamma function, a second degree polynomial, and both of these models with a lag variable. Bovine respiratory syncytial virus reinfections seemed to have only a small effect on the daily milk production. Comparison of the true production with an estimated production according to the gamma function showed that the production for first lactation cows dropped 0.14 kg on average and for cows in their second or later lactation 0.56 kg on average, during 5 consecutive days in the infection period. For the second‐degree polynomial model these values were respectively 0.42 kg and 0.80 kg. All calculated average production losses were relatively small and not significant (P>0.15). The models without lag variable were more suitable than the models with the lag variable to estimate small production losses caused by BRSV reinfections. The power of this study was sufficient to detect a decrease in production of approximately 1 ‐ 1.5 kg milk per cow per day. It was therefore concluded that BRSV reinfections were not associated with an important loss of milkproduction.